
Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to existing ones, which allows them to build monopolies, block competition and drive prices up. Health justice lawyer Priti Krishtel sheds light on how we've lost sight of the patent system's original intent -- and offers five reforms for a redesign that would serve the public and save lives.
اگر پخش یا دانلود این قسمت خراب است، به مدیر اطلاع دهید.
Roughly 85 percent of mass in the universe is "dark matter" -- mysterious material that can't be directly observed but has an immense influence on the cosmos. What exactly is this strange stuff, and what does it have to…
We are all connected by the spectacular birth, death and rebirth of stars, says astrophysicist Enrico Ramirez-Ruiz. Journey through the cosmic history of the universe as Ramirez-Ruiz explains how supernovas forged the…
Could the strange orbits of small, distant objects in our solar system lead us to a big discovery? Planetary astronomer Mike Brown proposes the existence of a new, giant planet lurking in the far reaches of our solar…
In this quick, fun talk, astronaut Cady Coleman welcomes us aboard the International Space Station, where she spent nearly six months doing experiments that expanded the frontiers of science. Hear what it's like to fly…
We're in the dawn of a new space revolution, says engineer Peter Beck: the revolution of the small. In a talk packed with insights into the state of the space industry, Beck shares his work building rockets capable of…